Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LRP23023 vs Cysteamine 5% in Facial Epidermal Melasma
NCT06278948Recruiting
- Sponsor
- Cosmetique Active International
- Start
- Oct 2023
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Randomised, single-blind trial in Melasma (2 arms), sponsored by Cosmetique Active International. Primary endpoints: Change in modified Melasma Area and Severity Index at Day 112 and Change in Investigator's Global Assessment at Day 112. Started Oct 2023; status: recruiting.
02
Conditions
Melasma
Beyond the preview
Go deeper on NCT06278948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06278948.